PDB Short entry for 1H8G HEADER CHOLINE-BINDING DOMAIN 06-FEB-01 1H8G TITLE C-TERMINAL DOMAIN OF THE MAJOR AUTOLYSIN (C-LYTA) FROM STREPTOCOCCUS TITLE 2 PNEUMONIAE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAJOR AUTOLYSIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CHOLINE-BINDING DOMAIN; COMPND 5 SYNONYM: C-LYTA, CELL WALL BINDING DOMAIN; COMPND 6 EC: 3.5.1.28; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 1313; SOURCE 4 CELLULAR_LOCATION: EXTRACELLULAR; SOURCE 5 GENE: LYTA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PCE17 KEYWDS CHOLINE-BINDING DOMAIN, CELL WALL ATTACHMENT EXPDTA X-RAY DIFFRACTION AUTHOR C.FERNANDEZ-TORNERO,E.GARCIA,R.LOPEZ,G.GIMENEZ-GALLEGO,A.ROMERO REVDAT 3 24-JUL-19 1H8G 1 REMARK LINK REVDAT 2 24-FEB-09 1H8G 1 VERSN REVDAT 1 31-JAN-02 1H8G 0 JRNL AUTH C.FERNANDEZ-TORNERO,R.LOPEZ,E.GARCIA,G.GIMENEZ-GALLEGO, JRNL AUTH 2 A.ROMERO JRNL TITL A NOVEL SOLENOID FOLD IN THE CELL WALL ANCHORING DOMAIN OF JRNL TITL 2 THE PNEUMOCOCCAL VIRULENCE FACTOR LYTA JRNL REF NAT.STRUCT.BIOL. V. 8 1020 2001 JRNL REFN ISSN 1072-8368 JRNL PMID 11694890 JRNL DOI 10.1038/NSB724 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.M.SANCHEZ-PUELLES,J.M.SANZ,J.L.GARCIA,E.GARCIA REMARK 1 TITL CLONING AND EXPRESSION OF GENE FRAGMENTS ENCODING THE REMARK 1 TITL 2 CHOLINE-BINDING DOMAIN OF PNEUMOCOCCAL MUREIN HYDROLASES REMARK 1 REF GENE V. 89 69 1990 REMARK 1 REFN ISSN 0378-1119 REMARK 1 PMID 1973677 REMARK 1 DOI 10.1016/0378-1119(90)90207-8 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.31 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1544106.380 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 12994 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1046 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1953 REMARK 3 BIN R VALUE (WORKING SET) : 0.3170 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 168 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1552 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 61 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.01000 REMARK 3 B22 (A**2) : 7.01000 REMARK 3 B33 (A**2) : -14.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.39 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.42 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.680 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.600 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.760 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.010 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.910 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 44.61 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SEVERAL CYCLES WITH CNS, ONE SHELX REMARK 3 CYCLE TO FIND WATER MOLECULES, FINAL CYCLE WITH CNS REMARK 4 REMARK 4 1H8G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-FEB-01. REMARK 100 THE DEPOSITION ID IS D_1290005858. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUL-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9073 REMARK 200 MONOCHROMATOR : GE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12997 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 8.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.36800 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: A FIRST STRUCTURE, WHOSE STATISTICS HAVE NOT BEEN REMARK 200 SUBMITTED, WAS DETERMINED TO 3.0 ANGSTROM RESOLUTION THROUGH A REMARK 200 MAD EXPERIMENT. A SECOND EXPERIMENT WAS THEN PERFORMED ON A REMARK 200 SINGLE CRYSTAL. IT IS STRUCTURE REFINED AGAINST THE DATA FROM REMARK 200 THIS SECOND EXPERIMENT THAT IS PRESENTED IN THIS ENTRY REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% MPD, 0.2 M NACL, 0.1 M NA-ACETATE, REMARK 280 PH 4.6, 0.2 M GUANIDINE-HCL, 0.15 M CHOLINE-CL., PH 4.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.24100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 48.78550 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 48.78550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 17.12050 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 48.78550 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 48.78550 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 51.36150 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 48.78550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 48.78550 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 17.12050 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 48.78550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 48.78550 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 51.36150 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 34.24100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE CHOLINE-BINDING DOMAIN FRAGMENT REMARK 300 CRYSTALLISES AS ATETRAMERIC ASSEMBLY FORMING A REMARK 300 CYCLIC DOUGHNUT STRUCTURE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 68.48200 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR B 224 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP B 225 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 265 76.00 53.13 REMARK 500 ASP A 266 -21.79 75.65 REMARK 500 LYS B 274 -80.41 -80.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHT A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHT A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHT A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHT B 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHT B 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHT B 406 DBREF 1H8G A 224 318 UNP P06653 ALYS_STRPN 224 318 DBREF 1H8G B 224 318 UNP P06653 ALYS_STRPN 224 318 SEQADV 1H8G MSE A 237 UNP P06653 MET 237 MODIFIED RESIDUE SEQADV 1H8G MSE A 257 UNP P06653 MET 257 MODIFIED RESIDUE SEQADV 1H8G MSE A 278 UNP P06653 MET 278 MODIFIED RESIDUE SEQADV 1H8G MSE B 237 UNP P06653 MET 237 MODIFIED RESIDUE SEQADV 1H8G MSE B 257 UNP P06653 MET 257 MODIFIED RESIDUE SEQADV 1H8G MSE B 278 UNP P06653 MET 278 MODIFIED RESIDUE SEQRES 1 A 95 THR ASP GLY ASN TRP TYR TRP PHE ASP ASN SER GLY GLU SEQRES 2 A 95 MSE ALA THR GLY TRP LYS LYS ILE ALA ASP LYS TRP TYR SEQRES 3 A 95 TYR PHE ASN GLU GLU GLY ALA MSE LYS THR GLY TRP VAL SEQRES 4 A 95 LYS TYR LYS ASP THR TRP TYR TYR LEU ASP ALA LYS GLU SEQRES 5 A 95 GLY ALA MSE VAL SER ASN ALA PHE ILE GLN SER ALA ASP SEQRES 6 A 95 GLY THR GLY TRP TYR TYR LEU LYS PRO ASP GLY THR LEU SEQRES 7 A 95 ALA ASP ARG PRO GLU PHE THR VAL GLU PRO ASP GLY LEU SEQRES 8 A 95 ILE THR VAL LYS SEQRES 1 B 95 THR ASP GLY ASN TRP TYR TRP PHE ASP ASN SER GLY GLU SEQRES 2 B 95 MSE ALA THR GLY TRP LYS LYS ILE ALA ASP LYS TRP TYR SEQRES 3 B 95 TYR PHE ASN GLU GLU GLY ALA MSE LYS THR GLY TRP VAL SEQRES 4 B 95 LYS TYR LYS ASP THR TRP TYR TYR LEU ASP ALA LYS GLU SEQRES 5 B 95 GLY ALA MSE VAL SER ASN ALA PHE ILE GLN SER ALA ASP SEQRES 6 B 95 GLY THR GLY TRP TYR TYR LEU LYS PRO ASP GLY THR LEU SEQRES 7 B 95 ALA ASP ARG PRO GLU PHE THR VAL GLU PRO ASP GLY LEU SEQRES 8 B 95 ILE THR VAL LYS MODRES 1H8G MSE A 237 MET SELENOMETHIONINE MODRES 1H8G MSE A 257 MET SELENOMETHIONINE MODRES 1H8G MSE A 278 MET SELENOMETHIONINE MODRES 1H8G MSE B 237 MET SELENOMETHIONINE MODRES 1H8G MSE B 257 MET SELENOMETHIONINE MODRES 1H8G MSE B 278 MET SELENOMETHIONINE HET MSE A 237 8 HET MSE A 257 8 HET MSE A 278 8 HET MSE B 237 8 HET MSE B 257 8 HET MSE B 278 8 HET CHT A 401 7 HET CHT A 402 7 HET CHT A 403 7 HET CHT B 404 7 HET CHT B 405 7 HET CHT B 406 7 HETNAM MSE SELENOMETHIONINE HETNAM CHT CHOLINE ION FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 CHT 6(C5 H14 N O 1+) FORMUL 9 HOH *61(H2 O) HELIX 1 1 ASP A 303 PRO A 305 5 3 HELIX 2 2 ASP B 303 PRO B 305 5 3 SHEET 1 CC 2 ASN A 227 PHE A 231 0 SHEET 2 CC 2 ASN B 227 PHE B 231 -1 O ASN B 227 N PHE A 231 SHEET 1 AA 2 GLY A 240 ILE A 244 0 SHEET 2 AA 2 LYS A 247 PHE A 251 -1 N PHE A 251 O GLY A 240 SHEET 1 AB 2 GLY A 260 TYR A 264 0 SHEET 2 AB 2 THR A 267 LEU A 271 -1 O LEU A 271 N GLY A 260 SHEET 1 AC 2 ALA A 282 SER A 286 0 SHEET 2 AC 2 GLY A 291 LEU A 295 -1 N LEU A 295 O ALA A 282 SHEET 1 AD 2 GLU A 306 GLU A 310 0 SHEET 2 AD 2 LEU A 314 LYS A 318 -1 O LYS A 318 N GLU A 306 SHEET 1 BA 2 GLY B 240 ILE B 244 0 SHEET 2 BA 2 LYS B 247 PHE B 251 -1 N PHE B 251 O GLY B 240 SHEET 1 BB 2 GLY B 260 TYR B 264 0 SHEET 2 BB 2 THR B 267 LEU B 271 -1 O LEU B 271 N GLY B 260 SHEET 1 BC 2 ALA B 282 SER B 286 0 SHEET 2 BC 2 GLY B 291 LEU B 295 -1 N LEU B 295 O ALA B 282 SHEET 1 BD 2 GLU B 306 GLU B 310 0 SHEET 2 BD 2 LEU B 314 LYS B 318 -1 O LYS B 318 N GLU B 306 LINK C GLU A 236 N MSE A 237 1555 1555 1.33 LINK C MSE A 237 N ALA A 238 1555 1555 1.33 LINK C ALA A 256 N MSE A 257 1555 1555 1.33 LINK C MSE A 257 N LYS A 258 1555 1555 1.33 LINK C ALA A 277 N MSE A 278 1555 1555 1.33 LINK C MSE A 278 N VAL A 279 1555 1555 1.33 LINK C GLU B 236 N MSE B 237 1555 1555 1.33 LINK C MSE B 237 N ALA B 238 1555 1555 1.33 LINK C ALA B 256 N MSE B 257 1555 1555 1.33 LINK C MSE B 257 N LYS B 258 1555 1555 1.33 LINK C ALA B 277 N MSE B 278 1555 1555 1.33 LINK C MSE B 278 N VAL B 279 1555 1555 1.33 SITE 1 AC1 2 TRP A 261 TYR A 293 SITE 1 AC2 3 TRP A 248 TYR A 269 ASP A 298 SITE 1 AC3 1 TYR A 229 SITE 1 AC4 5 THR A 224 ASP A 312 LYS B 242 TRP B 261 SITE 2 AC4 5 LEU B 301 SITE 1 AC5 3 LYS A 274 GLU A 275 TYR B 249 SITE 1 AC6 1 TYR B 229 CRYST1 97.571 97.571 68.482 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010249 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010249 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014602 0.00000 MTRIX1 1 -0.755710 -0.197380 -0.624460 154.17360 1 MTRIX2 1 -0.252030 -0.792410 0.555480 119.12921 1 MTRIX3 1 -0.604470 0.577170 0.549080 17.23518 1